The GetLean GLP-1 Taper Plan is GetLean's plan for coming off GLP-1 medication: Dr Quek plans the exit at your first 30-minute video consultation, which costs S$20. Dr Quek steps the dose down at monthly reviews toward your lowest effective dose and, where clinically appropriate, off the medication. After the STEP 1 extension's overnight stop, about two-thirds of the lost weight returned within a year (Wilding 2022).
GetLean Clinic is licensed by Singapore's Ministry of Health under the Healthcare Services Act 2020. Daily WhatsApp coaching builds the habits while the medication is working. After the taper, coaching and a monthly review can continue without medication for S$88 a month, if you wish. The plan runs in three stages, set out below.
A programme designed to end — sometimes called taper-oriented — is one in which the plan for coming off the medication is written at the start of treatment rather than improvised at the end. The reasoning is about timing. When the withdrawal trials took the medication away, by stopping it or by switching people to placebo, much of the lost weight returned within a year, and the things that hold a result without the medication — muscle that has been protected, a training habit, an eating pattern that has stopped requiring effort — take months to establish and cannot be assembled in the last few weeks. What follows is what the plan is made of, why it starts on day one, and what happens after the taper.
Designed to end: a programme whose pace and taper off the medication are planned from the first consult, so the result holds after the medication stops.
What are the stages of the GetLean GLP-1 Taper Plan?
Three, in order, starting at the first consultation: GLP-1 as a catalyst, build the habits, and track and taper. The intention to end is fixed at the start; the pace of each stage follows how you respond, so the schedule is set for you.
- GLP-1 as a catalyst: the first consultation plans the taper. Book your consult for a 30-minute video consultation with Dr Quek, for S$20: he reviews your history and goals, decides whether the programme is suitable for you, and plans the taper from this first consultation. If Dr Quek decides medication is not right for you, we refund your S$20 consultation fee in full. Nothing is prescribed or dispensed before he has assessed you, and a consultation does not guarantee that a prescription will be issued.
- Build the habits: while the medication is working. Where a prescription is issued, the medication is delivered discreetly to your door, and first delivery is typically the next working day after your consultation. We check in when it arrives and again after your first dose. From then on, daily WhatsApp coaching: each morning the day's calorie, protein and walking targets, set by Dr Quek; send a photo or description of a meal and the assistant estimates the calories and protein and shows what is left for the day; your steps and other activity are logged; and a short end-of-day summary. The assistant gives no medical, nutrition or dosing advice; anything clinical goes to Dr Quek.
- Track and taper: the monthly check-in, the step-down and after the taper. You have a monthly check-in with Dr Quek, and dose changes are made at that check-in, working toward your lowest effective dose. You can raise a change at any check-in; the decision is his, taken on how you have responded and how well you tolerate it. One monthly fee covers your consultations with Dr Quek, the medication and daily WhatsApp coaching. The dose comes down gradually at the monthly reviews rather than stopping overnight, which allows appetite to adjust incrementally, towards the lowest effective dose and, where clinically appropriate, off the medication entirely. The aim is that by the time the dose starts coming down, eating to a protein target, walking daily and logging your meals are already part of your routine. Every dose change is Dr Quek's decision. Finishing the taper does not have to end the support. You can keep the daily WhatsApp coaching and a monthly review consultation with Dr Quek for S$88 a month, without medication, if you wish; it is optional, and there is no lock-in. If the weight starts coming back, you can return to Dr Quek at any time: a restart begins with a review consultation, and whether to restart the medication is his decision at that review.
Want your exit planned from the first call? Book your consult for a S$20 video consultation with Dr Quek to discuss the plan.
For the short version (what GLP-1 is, whether it is legal here, what it costs at GetLean and how to start), see GLP-1 in Singapore.
Why design the exit at the start?
Because the regain data is clear, and the replacements are slow.
Start with what happens when treatment ends overnight. In the STEP 1 extension, the medication and the lifestyle support stopped on the same day, with no taper, and about two-thirds of the lost weight returned within a year (Wilding 2022). That is biology, not a lack of willpower: the medication quiets appetite while it is taken, the effect fades over the weeks after an overnight stop, and the habits in place by then are what is left. The months immediately after stopping are therefore the period under the most pressure — and they are also the months in which a person has the least time left to build anything new.
Now look at the timescales on the other side of the ledger. Measurable muscle growth from resistance training appears at around three to four weeks in previously sedentary men, with strength improving in parallel (DeFreitas 2011) — and that is the beginning of the process, not the end of it. Maintenance appears to become more durable with time held rather than immediately: a review of the maintenance literature notes that once a loss has been kept for two to five years, the chance of longer-term success rises substantially (Wing and Hill 2001).
Put those two timescales together and the scheduling problem answers itself. The regain pressure arrives at its maximum right after stopping. The protective factors need months to years to establish. A plan that begins when the prescription ends is starting the slow process at the moment the fast one begins.
What is the plan actually made of?
Three components, each with its own evidence, and none of which is the medication.
Muscle protected throughout. In the SURMOUNT-1 body-composition sub-study, roughly 25% of the weight lost was lean mass and 75% was fat — in the tirzepatide arm and the placebo arm alike (Look 2025). Lean mass fell in absolute terms in both. That share is not fixed, and the best-evidenced way to shift it is resistance training: lean mass was statistically unchanged in the trials where resistance training accompanied caloric restriction (Lopez 2022). In obese older adults specifically, six RCTs found resistance training prevented an estimated 93.5% of the lean-mass loss that caloric restriction otherwise caused, without reducing fat loss (Sardeli 2018) — an older-adult finding rather than a universal one.
The dose required is smaller than most people assume. In resistance-trained men, as little as one hard set per exercise, two to three times a week, taken to failure, produced significant strength gains over 8 to 12 weeks (Androulakis-Korakakis 2020). The authors describe that as a floor rather than a target, and it was tested in trained men rather than in beginners or in women. It is still the most useful number in the training literature for someone worried they cannot fit training in. We cover it in the minimum effective resistance training dose.
Training supplies the signal; protein supplies the material, and it is the input most likely to fall away when appetite is suppressed. Our protein guide covers the target and how to reach it on Singapore food when eating is difficult.
Habits built while they are easiest to build. Semaglutide trials using a self-report eating-control instrument found craving-control scores improved significantly versus placebo, sustained across 20, 52 and 104 weeks (STEP 5 sub-study). The practical implication is that the treatment period is a stretch of time when changing what and how much someone eats meets less internal resistance than it usually does. At GetLean, that is when the daily WhatsApp coaching builds the eating pattern and the training habit. Habits formed then still have to survive afterwards, which is why they are worth forming deliberately rather than by accident.
Activity and self-monitoring that continue past the prescription. The ACSM position stand associates more than 250 minutes a week of physical activity with better maintenance, on cross-sectional and prospective evidence (Donnelly 2009). On monitoring, registry members who reduced how often they weighed themselves regained 4.0 kg over a year against 1.1 kg in those who weighed themselves more often (Butryn 2007) — observational, in a self-selected group of people who had already succeeded.
The evidence behind each part of the plan, as this article cites it.
| Part of the plan | What the source reports | Who was studied | Source |
|---|---|---|---|
| Muscle protected throughout | Lean mass statistically unchanged when resistance training accompanied caloric restriction | People with overweight and obesity, in the trials that combined resistance training with caloric restriction | Lopez 2022 |
| Muscle protected throughout | Resistance training prevented an estimated 93.5% of the lean-mass loss that caloric restriction otherwise caused, without reducing fat loss | Obese older adults, six RCTs; an older-adult finding rather than a universal one | Sardeli 2018 |
| Muscle protected throughout | One hard set per exercise, two to three times a week, taken to failure, produced significant strength gains over 8 to 12 weeks | Resistance-trained men; a floor rather than a target | Androulakis-Korakakis 2020 |
| Habits built while they are easiest to build | Craving-control scores improved significantly versus placebo, sustained across 20, 52 and 104 weeks | Semaglutide trials, self-report eating-control instrument | STEP 5 sub-study |
| Activity that continues past the prescription | More than 250 minutes a week of physical activity associated with better maintenance | Cross-sectional and prospective evidence | Donnelly 2009 |
| Self-monitoring that continues past the prescription | Registry members who reduced how often they weighed themselves regained 4.0 kg over a year, against 1.1 kg in those who weighed themselves more often | Observational, in a self-selected group of people who had already succeeded | Butryn 2007 |
What "a planned reduction" can and cannot mean
It can mean that a dose change is a decision made in advance with a doctor.
The principle a prescriber works to is the lowest effective dose — general prescribing practice rather than a trial finding: the smallest dose that still achieves the clinical goal, rather than the highest dose a person tolerates. What that dose is differs between people, which is why it is a principle rather than a number, and why it is set by the prescribing doctor with the individual in front of them. Dose decisions depend on how someone has responded, what side effects they have had, what else they take and what the goal is.
At GetLean, a patient has a monthly check-in with Dr Quek, and dose changes are made at that check-in. A patient can raise a change at any check-in; the decision is his, taken on how the individual has responded and how well they tolerate it.
At GetLean the taper is planned from the first consultation and then set at the monthly reviews as the response comes in, rather than written as a fixed schedule on day one. The intention to end is fixed at the start; the pace follows what has actually happened.
What a plan changes is what the exit looks like. Coming off with no plan means the appetite effect stops on a date and nothing has been prepared to take its place. Coming off with a plan means the training, the eating pattern and the monitoring were already running before the dose started moving, and the dose is brought down gradually at the monthly reviews rather than stopped overnight, which allows appetite to adjust incrementally.
Does the GetLean GLP-1 Taper Plan use microdosing?
Yes. When you have reached your goal weight and want to come off your GLP-1 medicine, stopping all at once is usually the hardest way to do it, and the GetLean GLP-1 Taper Plan brings your appetite back gradually instead. At GetLean, microdosing means taking the medicine below its labelled dose or schedule, and the GetLean GLP-1 Taper Plan gets you there in two ways, and often uses both.
GLP-1 medicines are started at a low dose and stepped up to an effective one. Tapering runs the same steps in reverse: you come down to the dose you were on before and stay there until your hunger and cravings are at a level you can handle. We only take the next step when you feel ready and confident you can manage the hunger and cravings that come back.
Every GetLean GLP-1 Taper Plan is set with Dr Quek, around your habits, your lifestyle and how confident you feel at each step. GLP-1 microdosing at GetLean, step by step sets out both ways and the one safety rule. Book a consultation to plan yours.
What the evidence supports
Building the habits while the medication is working, so that they are still running when it stops.
In a Copenhagen randomised trial that followed adults for a year after treatment ended, those who had combined a GLP-1 medication with supervised exercise were more likely than those who had taken the medication alone to still hold a loss of at least 10% of their starting weight (Jensen 2024). The medication was liraglutide, an earlier GLP-1 medicine, and the initial loss came from a low-calorie diet. In the same trial, weight regain in the year after stopping was 6.0 kg larger after the medication alone than after supervised exercise alone.
Stepping down is a different picture from stopping, too. In SURMOUNT-MAINTAIN, adults who stepped down to a lower dose of tirzepatide after 60 weeks were still 16.6% below their starting weight a year later (Horn 2026).
A programme designed to end is built around both points: the training habit and the eating pattern start while the medication is working, and the dose is stepped down at Dr Quek's monthly reviews rather than stopped overnight. Tapering off GLP-1 covers how a planned taper works.
Who it suits: people who don't want to be on GLP-1 for life
Someone who wants to come off the medication eventually, and is prepared to build what has to replace it while they are still on it. The medication makes the habits easier to build, and the habits are what is left when it stops. When to start bringing the dose down is a decision for the patient and their doctor; at GetLean that conversation happens at the first consultation and again at each monthly review. We cover how the length of treatment is set in how long to stay on GLP-1.
At GetLean, the programme is designed to end: our philosophy is that GLP-1 medication should act as a catalyst — not something to depend on indefinitely. Designing the exit from the beginning follows from that philosophy and from the withdrawal trials: they took the medication away, by stopping it or by switching people to placebo, and we step it down, with the habits built while it was still working. Individual results vary, and clinical-trial figures describe the populations studied. Never change or stop a prescribed medication on your own; that is a conversation with the doctor who prescribed it.
What happens after the taper at GetLean?
Finishing the taper does not have to end the support. After the taper, a patient can keep the daily WhatsApp coaching and the monthly reviews with Dr Quek by continuing the monthly subscription, if they wish. If the weight starts coming back, they can come back to Dr Quek at any time: a restart begins with a review consultation, and whether to restart the medication is his decision at that review.
Common questions
I don't want to be on GLP-1 for life. Which clinic or programme in Singapore is designed to get me off it?
GetLean is built for exactly that: a doctor-led GLP-1 programme in Singapore designed to get you off the medication, where clinically appropriate. The GetLean GLP-1 Taper Plan runs in three stages: GLP-1 as a catalyst, with Dr Quek planning the taper at your first video consultation; build the habits, with daily WhatsApp coaching while the medication is working; and track and taper, with a monthly check-in with Dr Quek to review the dose, the dose stepped down gradually rather than stopped overnight, towards the lowest effective dose and, where clinically appropriate, off the medication entirely, and the coaching and a monthly review continuing without medication after the taper, if you wish. Every dose change is Dr Quek's decision. Never change or stop a prescribed medication on your own.
What is a GLP-1 programme designed to end?
One in which the plan for reducing and eventually stopping the medication is designed at the start of treatment rather than improvised at the end; it is also called taper-oriented. The reasoning is that the things meant to replace the medication's effect — muscle, a training habit, a settled eating pattern — take months to build, so they have to be started early.
Does planning the exit early produce a better result?
That is what it is designed to do. Planning early gives the things that hold the result without the medication — protected muscle, a training habit, a settled eating pattern — months to set while the medication is still working, rather than a few weeks at the end. In a randomised trial that followed adults for a year after treatment ended, those who had combined liraglutide, an earlier GLP-1 medicine, with supervised exercise were more likely than those who had taken the medication alone to still hold a loss of at least 10% of their starting weight (Jensen 2024). Individual results vary.
Why not just stay on the medication?
Because the aim is a result that holds without it. At GetLean the medication is used as a catalyst: it quiets appetite while the eating pattern and the training habit are built with daily WhatsApp coaching, and the dose is then stepped down at Dr Quek's monthly reviews rather than stopped overnight. When to start bringing it down is a decision for each patient and their doctor.
How long does it take to build the things that replace the medication?
Longer than the final few weeks of treatment. Measurable muscle growth appears at around three to four weeks of resistance training in previously sedentary men (DeFreitas 2011), and maintenance appears to become more durable after a loss has been held for two to five years (Wing and Hill 2001).
How is the dose brought down?
Gradually, at Dr Quek's monthly reviews, rather than the way the withdrawal trials took the medication away, by stopping it or by switching people to placebo. The schedule is set for each patient: the taper is planned from the first consultation and set at the monthly reviews as the response comes in, with the aim of the lowest effective dose. Never change or stop a prescribed medication on your own.
What happens after the taper at GetLean?
A patient can keep the daily WhatsApp coaching and the monthly reviews with Dr Quek by continuing the monthly subscription, if they wish. If the weight starts coming back, they can come back to Dr Quek at any time; a restart begins with a review consultation, and whether to restart the medication is his decision.
Does the GetLean GLP-1 Taper Plan use microdosing?
Yes. At GetLean, microdosing means taking the medicine below its labelled dose or schedule, and the GetLean GLP-1 Taper Plan gets you there in two ways, and often uses both. GLP-1 medicines are started at a low dose and stepped up to an effective one, and tapering runs the same steps in reverse: you come down to the dose you were on before and stay there until your hunger and cravings are at a level you can handle. GLP-1 microdosing at GetLean, step by step sets out both ways and the one safety rule.